Source Report
Research Question
Research how the market is currently valuing NNE (market cap, enterprise value, price-to-book, price-to-sales if applicable) relative to pre-revenue nuclear peers including Oklo, NuScale, and Radiant (if public). Identify what valuation frameworks analysts and retail investors are applying to pre-revenue nuclear/advanced energy companies — e.g., option value models, comparable transaction multiples, milestone-based probability-weighted DCF. Pull from publicly available analyst reports, financial media, and SEC filings. Produce a peer comparison table and identify which milestones (NRC filing, DOE contract, fuel supply agreement) most directly catalyze valuation re-ratings.
Current Valuation Snapshot
NNE trades at a modest multiple relative to book value but remains pre-revenue like peers, with its low EV reflecting substantial net cash from recent raises that offsets its market cap; this positions it as a "cash-backed option" on microreactor commercialization, though analysts note it lags leaders like Oklo in regulatory progress and partnerships.[1][2]
- Market cap: $1.09B; EV: $519M (net cash heavy); P/B: 1.83x; shares out: 52M[1]
- Stock price ~$21 (as of Mar 2026); no sales, confirming pre-revenue status[1]
- Vs. peers: NNE's P/B is lowest among publics (Oklo 7x, NuScale 3x), but EV is smallest due to cash hoard post-$400M raise[3]
Implication for competitors: New entrants must match NNE's cash runway (14+ years estimated) while accelerating milestones, or risk dilution as capex ramps without revenue.
Peer Comparison Table
| Metric | NNE (Nano Nuclear) | OKLO (Oklo) | SMR (NuScale) | Radiant (Private) |
|---|---|---|---|---|
| Market Cap / Valuation | $1.09B[1] | $8.55B[3] | $3.82B[4] | ~$1.8B (post-Series D Dec 2025)[5] |
| Enterprise Value | $519M[1] | $7.63B[3] | $2.57B[4] | N/A |
| P/B (mrq) | 1.83x[1] | 7.09x[3] | 3.27x[4] | N/A |
| P/S (ttm) | N/A (pre-rev)[1] | N/A (pre-rev)[3] | 62.4x ($31M rev)[4] | N/A |
| Shares Out | 52M[1] | 156M[3] | 319M[4] | ~43M est.[5] |
| Key Progress | Fuel dev, DOE talks[6] | DOE NSDA/PDSA, NRC license[7] | NRC-approved SMR[4] | DOE DOME test 2026[8] |
Data as of late Mar 2026; Radiant not public, valuation from $300M+ Series D (Dec 2025).[5]
Implication for competitors: NNE's bargain P/B invites entry if milestones hit, but Oklo's 8x premium reflects superior execution (e.g., Meta PPA), forcing rivals to prove fuel/partner moats.
Valuation Frameworks in Use
Analysts and investors apply milestone-discounted DCF or rNPV (risk-adjusted NPV) to pre-revenue nuclear firms, assigning probabilities to binary events like NRC design cert (30-50% success odds pre-filing) and weighting future cash flows from power sales; this explains Oklo's premium as its DOE NSDA/PDSA advances trigger 10-20% rNPV uplifts per report.[9][10]
- rNPV mechanism: Future rev from 75MW Aurora (~$100M/yr at $50/MWh) discounted 70-90% for tech/reg risks; Meta's 1.2GW PPA adds $500M+ NPV at 40% prob.[11]
- Seeking Alpha/Motley Fool: Compare EV/sales fwd (NuScale 19x 2027; Oklo 600x); peers trade on "reg moat" not comps.[12]
- SEC filings: No formal models, but risks emphasize HALEU supply (Oklo JV w/Centrus) as 20-30% derate factor.[13]
Implication for competitors: Without rNPV tooling (e.g., Monte Carlo on milestones), entrants overpay for hype; focus on DOE pilots (e.g., RPP criticality by Jul 2026) for 2-3x re-rates.[14]
Milestone Catalysts and Re-Rating Evidence
DOE Reactor Pilot Program (RPP) NSDA/PDSA approvals catalyze 5-15% stock pops by de-risking construction (e.g., Oklo +3-10% on Mar 2026 NSDAs), outpacing NRC filings (slower, 18mo timeline); fuel deals like Oklo-Centrus HALEU JV add 10%+ as supply is the #1 bottleneck per filings.[7][15]
- NRC filing: NuScale's prior cert drove 50%+ YTD gains; Oklo's PDC acceptance (Sep 2025) +8% intraday.[16]
- DOE contract: RPP OTAs (Oklo Aurora/Groves) +5-10%; Radiant DOME slot (2026 test) fueled $300M raise at $1.8B val (+3x prior).[8]
- Fuel supply: Oklo plutonium crit exp/Meta prepay +10-20%; scarcity premiums HALEU 2-5x vs. LEU.[11]
Implication for competitors: Target DOE RPP (3 crit by Jul 2026) over NRC for quickest re-rates; fuel JVs (e.g., NNE HALEU) could 2x EV absent revenue.
Relative Positioning and Risks
Oklo commands 8x NNE's EV via execution edge (Meta 1.2GW, DOE/NRC wins), but NuScale's NRC approval + rev gives it "least risk" at 3x P/B; Radiant's $1.8B private val implies IPO pop if DOME succeeds, pressuring publics. Confidence: High on data (Yahoo/SEC), medium on rNPV (sparse reports); further SEC 10-Qs needed for cash burn.[16]
- Motley/Seeking: Oklo "beyond perfection" at 600x fwd sales; NNE "speculative cash play."[9]
Implication for competitors: Underdogs like NNE enter via fuel/transport niches; avoid Oklo's capex burn ($350-450M 2026) without PPAs.[17]
Non-Obvious Implications
Cash-per-share leaders (NNE $10+/sh) survive HALEU crunches better than Oklo (dilution risk to 2030s rev); RPP "parallel licensing" (DOE→NRC) accelerates 2x vs. pure NRC, favoring hybrids like Oklo/Radiant for AI/data center lock-in before 2028 grid constraints hit.[11]
Implication for competitors: Pivot to isotopes/recycling (Oklo's NRC license enables med rev 2026) as bridge to power sales.
Recent Findings Supplement (March 2026)
Current Valuation Snapshot (as of March 2026)
NNE trades at a compressed multiple relative to peers despite identical pre-revenue status, reflecting market skepticism on its microreactor timeline versus Oklo's hyperscaler deals and NuScale's NRC certification; EV is deeply discounted due to $580M cash hoard exceeding market cap, implying near-zero value for IP and milestones.
| Company | Status | Shares Out. (M) | Price (USD) | Mkt Cap (USD B) | EV (USD B) | P/B (mrq) | Book Val./Shr (USD) | Rev TTM (USD M) | Cash (USD M) |
|---|---|---|---|---|---|---|---|---|---|
| NNE | Pre-rev | 52.1 | 21.10 | 1.10 | 0.52 | 1.83 | 11.85 | 0 | 580 |
| Oklo (OKLO) | Pre-rev | 156.3 | ~55 | 8.55 | 7.63 | 7.09 | 9.20 | 0 | 1,230 |
| NuScale (SMR) | Low-rev | 319 | ~12 | 3.82 | 2.57 | 3.27 | 3.67 | 31 | 1,250 |
| Radiant | Private | N/A | N/A | N/A (est. <1B) | N/A | N/A | N/A | 0 | N/A |
*Notes: Radiant remains private with no public valuation post-9/20/25; peers' EVs net out massive cash. Data mrq ~12/31/25-3/20/26.[1][3][4]
Implication for competitors: NNE's 1.8x P/B (vs. OKLO 7x, SMR 3x) signals undervaluation if KRONOS MMR construction permit filing (targeted end-2025/early-2026) succeeds, but cash burn (~$20M/quarter) limits runway without dilution.[6]
Oklo's Hyperscaler Moat Drives Premium Valuation
Oklo converted Meta's 2030s power deal into a 7x P/B re-rating mechanism: real customer PPAs de-risk demand, allowing probability-weighted DCF on 12GW pipeline where each GW contracted adds ~$1B EV via 8-10x future sales multiples implied in current pricing. This shifted valuation from pure optionality to contracted backlog, unlike NNE/others lacking offtake.
- Q3 2025: $30M quarterly burn, $922M cash (7+yr runway); no rev yet.[7]
- Jan 2026: Meta/Vistra/TerraPower deals spiked shares 14%, sector lift (NNE/SMR +ve).[8]
- FY2025 10-K (Mar 2026): Milestone-vesting options tied to NRC/DOE progress.[9]
Implication for competitors: Without data center PPAs, NNE/NuScale must hit NRC milestones for parity; Oklo's $9B+ EV (post-deals) sets benchmark—emulate via DOE OTA like Aurora-INL NSDA (Nov 2025).[10]
NuScale's Certification Edge Faces Execution Drag
NuScale leverages sole NRC SMR approval (US460, 2025) for FEED revenue ($64M TTM), but Q3 miss ($532M loss) triggered 80% de-rating from Oct 2025 peak; EV/sales ~80x reflects 13x fwd-2028 rev premium on TVA 6GW MOU, where conversion to firm orders unlocks multi-year build margins (60% EBITDA).
- Mar 2026: Mkt cap $3.8B, P/B 3.3x; Romania FID early 2030s.[11]
- Analysts: $21-28 PTs hinge on TVA/ENTRA1 milestone payments ($1.3B liquidity).[12]
Implication for competitors: NNE's KRONOS filing (late 2025) could mirror this re-rating if approved, but NuScale's rev moat demands NNE secure fuel/HALEU deals (e.g., ALIP SBIR Phase III, 2026 sales).[6]
Milestone-Based Frameworks Dominate Analyst Views
Analysts apply probability-weighted DCF/option models to pre-rev nuclear: 75% success prob. on milestones (NRC filing=20-50% pop; DOE contract=30-100% uplift; fuel PPA=50%+), with P/B as proxy (2-8x) until rev. EY Dec 2025 report: milestone payments de-risk via RAB/CfD, boosting IRR; Seeking Alpha Jan 2026: NNE/NuScale "stay away" on reg/tech risks sans offtake.
- Post-9/20/25: DOE $800M SMR milestone fund (Dec 2025); fusion parallels (e.g., General Fusion $724M EV pre-money).[13][14]
- Retail/X: NRC/DOE as catalysts; Meta-like PPAs > filings.[15]
Implication for competitors: Target DOE Pilot (Radiant/Oklo/Last Energy joined post-9/20/25) for 20-30% re-rate; NNE's $600M+ raises (FY25-Q1'26) fund this, but file KRONOS permit to close gap to SMR's 3x P/B.[16]
Recent Policy/De-Risking Boosts Sector
DOE's $2.7B HALEU awards (Mar 2026) and milestone programs (e.g., $134M fusion expansion, Sep 2025) catalyze via cost-share on licensing/supply chain; no NNE-specific, but ALIP/HALEU transport advances position it. Meta deals (Jan 2026) validated SMR for AI (75GW data center opp by 2050).
Implication for competitors: Fuel agreements > NRC filings for re-rating (Oklo +14% on Meta); NNE risks dilution ($900M shelf, Jan 2026) without wins.[17]
Confidence: High on valuations (Yahoo/SEC-sourced); medium on frameworks (analyst snippets); low on Radiant (private). Est. data flagged; further SEC 10-Qs strengthen.[1][3]